-- Bio-Rad's Automated Droplet Generator delivers trusted,
high-quality results to a market characterized by increasingly
stringent regulations and standards
MOUNTAIN VIEW, California,
Jan. 28, 2015 /PRNewswire/ -- Based
on its recent analysis of the digital PCR (dPCR) market, Frost
& Sullivan recognizes Bio-Rad Laboratories, Inc. with the 2014
North American Frost & Sullivan Award for New Product
Innovation. Bio-Rad's solution, the Automated Droplet Generator
(AutoDG), enables a wide range of high-throughput digital PCR
applications by offering walk-away automation, scalability,
efficiency, and reproducibility to the dPCR workflow.
Photo - http://photos.prnewswire.com/prnh/20150113/168869
To build on its strong product portfolio in PCR and quantitative
PCR (qPCR), Bio-Rad acquired Droplet Digital™ PCR (ddPCR™)
technology developer QuantaLife in 2011. This acquisition resulted
in the commercialization of Bio-Rad's first-generation QX100™
Droplet Digital™ PCR System, which set the industry standard in
ease-of-use and provided traditional qPCR users with more precise
and accurate quantification of nucleic acids for previously unmet
needs in rare event detection, mutation and copy number analyses,
and gene expression.
In July 2013, Bio-Rad launched its
second-generation ddPCR instrument, the QX200™ Droplet Digital™ PCR
System. This instrument enables the use of both EvaGreen and TaqMan
hydrolysis probe detection chemistries and was the first digital
PCR system to provide such flexibility in experimental design. Both
the QX100 and QX200 instruments have aided numerous scientific
discoveries in the fields of cancer, liquid biopsy, virology, and
other diseases, leading to now close to 200 peer-reviewed papers
since 2011.
"Following the launch of the QX200 System, Bio-Rad extended its
dominance of the market by launching the AutoDG, a fast, fully
automated, walk-away instrument for generating droplets ready for
transfer to the thermal cycler and, subsequently, the droplet
reader," said Frost & Sullivan Senior Industry Analyst
Christi Bird. "This system has huge
implications for high sample throughput applications, such as
cancer screening, pathogen detection, clinical diagnostics,
environmental monitoring, and food testing."
The AutoDG automates the process of droplet generation,
generating droplets for 96 ddPCR reactions in less than 45 minutes,
a task that would require manual, hands-on time. Automating the
process not only frees up researchers for other laboratory tasks,
but eliminates human error and variance in pipetting, leading to
more reproducible data. In addition, the scalability delivered by
the AutoDG allows four to five QX100 or QX200 Droplet Readers to
run continuously for the highest throughput laboratories. It also
allows the plate layout to be defined by the user in increments of
eight wells in instances in which all wells are not required,
providing even more flexibility for various applications and
throughput needs.
Bio-Rad developed the AutoDG to be simple and easy to use. The
instrument features a large, color touchscreen interface and LED
lighting with simple guidance for setup and loading. Oil is
required to generate the droplets, and the instrument monitors and
displays the oil usage levels on the touchscreen. This takes the
guesswork out of reagent replacement and helps the laboratory keep
its ddPCR workflow up and running efficiently.
"The AutoDG is a major milestone for Bio-Rad's ddPCR portfolio
as it increases the efficiency and utility of Droplet Digital PCR
in higher-throughput workflows," states Bird. "Bio-Rad continues to
lead the market in breakthroughs to advance dPCR technology,
earning the company a reputation for innovation and a
market-leading position in the dPCR market."
For its commitment to introducing novel products to meet the
wide-ranging needs of the market, Frost & Sullivan presents the
2014 New Product Innovation Award for the Digital PCR Market to
Bio-Rad.
Each year, Frost & Sullivan presents this award to a company
that has developed an innovative element in a product by leveraging
leading-edge technologies. The award recognizes the value-added
features/benefits of the product and the increased ROI it offers
customers, which, in turn, increases customer acquisition and
overall market penetration potential.
Frost & Sullivan's Best Practices Awards recognize companies
in a variety of regional and global markets for outstanding
achievement in areas such as leadership, technological innovation,
customer service, and product development. Industry analysts
compare market participants and measure performance through
in-depth interviews, analysis, and extensive secondary
research.
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops,
manufactures, and markets a broad range of innovative products and
solutions for the life science research and clinical diagnostic
markets. The company is renowned for its commitment to quality and
customer service among university and research institutions,
hospitals, public health and commercial laboratories, as well as
the biotechnology, pharmaceutical, and food safety industries.
Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than
100,000 research and healthcare industry customers through its
global network of operations. The company employs approximately
7,800 people worldwide and had revenues exceeding $2.1 billion in 2013. For more information, visit
our website at www.bio-rad.com.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in
collaboration with clients to leverage visionary innovation that
addresses the global challenges and related growth opportunities
that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these
opportunities and incorporating two key elements driving visionary
innovation: The Integrated Value Proposition and The Partnership
Infrastructure.
- The Integrated Value Proposition provides support
to our clients throughout all phases of their journey to visionary
innovation including: research, analysis, strategy, vision,
innovation and implementation.
- The Partnership Infrastructure is entirely unique
as it constructs the foundation upon which visionary innovation
becomes possible. This includes our 360 degree research,
comprehensive industry coverage, career best practices as well as
our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth
strategies for the global 1000, emerging businesses, the public
sector and the investment community. Is your organization prepared
for the next profound wave of industry convergence, disruptive
technologies, increasing competitive intensity, Mega Trends,
breakthrough best practices, changing customer dynamics and
emerging economies?
Contact Us: Start the discussion
Join Us: Join our community
Subscribe: Newsletter on "the next big thing"
Register: Gain access to visionary innovation
Contact:
Mireya Espinoza
P: +1-210-247-3870
F: +1-210-348-1003
E: mireya.espinoza@frost.com